Belimumab
Products in Health Canada’s databases that list Belimumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 4
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 11
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| BENLYSTA (120 MG) | 02370050 | Marketed | Glaxosmithkline Inc | |
| BENLYSTA (400 MG) | 02370069 | Marketed | Glaxosmithkline Inc | |
| BENLYSTA (200 MG) | 02470489 | Marketed | Glaxosmithkline Inc | |
| BENLYSTA (200 MG) | 02470470 | Cancelled Pre Market | Glaxosmithkline Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- BENLYSTADecember 23, 2025 · NOC 36698
- BENLYSTAApril 1, 2025 · NOC 35139
- BENLYSTAMarch 15, 2024 · NOC 26254
- BENLYSTAMarch 6, 2024 · NOC 32834
- BENLYSTAMay 23, 2023 · NOC 30807
- BENLYSTAJuly 29, 2021 · NOC 26344
- BENLYSTAJanuary 8, 2021 · NOC 24988
- BENLYSTADecember 7, 2017 · NOC 20127
- BENLYSTASeptember 8, 2016 · NOC 18455
- BENLYSTANovember 20, 2014 · NOC 23270
- BENLYSTAJuly 6, 2011 · NOC 12482